Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 388

1.

Non-adherence to lipid-lowering therapies: a need for more studies to evaluate reasons for medication non-adherence.

Wong MC, Wang HH, Liu KS.

Int J Clin Pract. 2011 Dec;65(12):1321-2. doi: 10.1111/j.1742-1241.2011.02790.x. No abstract available.

PMID:
22093540
2.

Clinical and economic outcomes in patients switched to simvastatin in a community-based family medicine practice.

Willey VJ, Reinhold JA, Willey KH, Kelly BL, Cziraky MJ.

Int J Clin Pract. 2010 Aug;64(9):1235-8. doi: 10.1111/j.1742-1241.2010.02423.x.

PMID:
20653799
3.

Recent trials of lipid lowering.

Ray KK, Cannon CP, Braunwald E.

Int J Clin Pract. 2007 Jul;61(7):1145-59. Review.

4.

[Aggressive therapy and combination therapy in severe hyperlipidemia].

Kostner KM.

Wien Med Wochenschr. 1999;149(5-6):146-8. Review. German.

PMID:
10408007
5.

Achieving optimal lipid goals in patients with coronary artery disease.

Karalis DG, Subramanya RD, Hessen SE, Liu L, Victor MF.

Am J Cardiol. 2011 Mar 15;107(6):886-90. doi: 10.1016/j.amjcard.2010.11.006. Epub 2011 Jan 19.

PMID:
21247526
6.

[On the current debate on lowering LDL cholesterol with ezetimibe].

Breuer HW.

Dtsch Med Wochenschr. 2010 Nov;135(44):2201; author reply 2202. doi: 10.1055/s-0030-1267499. Epub 2010 Oct 26. German. No abstract available.

PMID:
20979008
7.

Trial clouds use of niacin with a statin.

[No authors listed]

Harv Heart Lett. 2011 Aug;21(12):2. No abstract available.

PMID:
21991606
8.

Lipid-lowering effects of ezetimibe and simvastatin in combination.

Ijioma N, Robinson JG.

Expert Rev Cardiovasc Ther. 2011 Feb;9(2):131-45. doi: 10.1586/erc.10.179. Review.

PMID:
21453210
9.

LDL-Cholesterol is the King.

Goumas GS.

Angiology. 2009 Jun-Jul;60(3):387-8. doi: 10.1177/0003319709334121. Epub 2009 Jun 3. No abstract available.

PMID:
19497926
10.

Comparative efficacy study of atorvastatin vs simvastatin, pravastatin, lovastatin and placebo in type 2 diabetic patients with hypercholesterolaemia.

Gentile S, Turco S, Guarino G, Sasso CF, Amodio M, Magliano P, Salvatore T, Corigliano G, Agrusta M, De Simone G, Gaeta I, Oliviero B, Torella R.

Diabetes Obes Metab. 2000 Dec;2(6):355-62.

PMID:
11225965
11.

Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.

Jones PH, Hunninghake DB, Ferdinand KC, Stein EA, Gold A, Caplan RJ, Blasetto JW; Statin Therapies for Elevated Lipid Levels Compared Across Doses to Rosuvastatin Study Group.

Clin Ther. 2004 Sep;26(9):1388-99. Erratum in: Clin Ther. 2005 Jan;27(1):142.

PMID:
15531001
12.

Lipid-modifying drugs.

Simons LA, Sullivan DR.

Med J Aust. 2005 Mar 21;182(6):286-9. Review.

PMID:
15777144
13.

No difference in plasma fibrinogen levels between CAPD patients taking atorvastatin and simvastatin.

Singhal MK, Bhaskaran S, Szabo T, La Rosa R.

Perit Dial Int. 1999 Jan-Feb;19(1):89-91. No abstract available.

PMID:
10201354
14.

[Update: clinical lipidology].

Parhofer KG.

MMW Fortschr Med. 2013 Jul 25;155(13):49-52; quiz 53-4. Review. German. No abstract available.

PMID:
23964509
15.

Changing face of dyslipidemia therapy.

Banerjee AK.

Indian Heart J. 2008 May-Jun;60(3):192-4. No abstract available.

PMID:
19240305
16.

Lipid management with statins. The lower the better?

Laufs U, Liao JK, Böhm M.

Z Kardiol. 2004 Jan;93(1):4-9. Review.

PMID:
14740235
17.

High HDL may not protect the heart. Concentrate on lowering LDL for now, experts advise.

[No authors listed]

Harv Heart Lett. 2012 Sep;23(1):6. No abstract available.

PMID:
23097807
18.

Lipid and apolipoprotein ratios: association with coronary artery disease and effects of rosuvastatin compared with atorvastatin, pravastatin, and simvastatin.

Rader DJ, Davidson MH, Caplan RJ, Pears JS.

Am J Cardiol. 2003 Mar 6;91(5A):20C-23C; discussion 23C-24C.

PMID:
12646340
19.

Comparison of combined statin-fibrate treatment to monotherapy in patients with mixed hyperlipidemia.

Kłosiewicz-Latoszek L, Szostak WB, Grzybowska B, Białobrzeska-Paluszkiewicz J, Wiśniewska B, Stolarska I.

Kardiol Pol. 2004 Jun;60(6):567-77. English, Polish.

PMID:
15334157
20.

Treatment of hypercholesterolemia and combined hyperlipidemia with simvastatin and gemfibrozil in patients with NIDDM. A multicenter comparison study.

Tikkanen MJ, Laakso M, Ilmonen M, Helve E, Kaarsalo E, Kilkki E, Saltevo J.

Diabetes Care. 1998 Apr;21(4):477-81.

PMID:
9571327

Supplemental Content

Support Center